Shanghai HeartCare Medical Technology Corporation Limited (HEARTCARE-B, 06609) has announced that its board of directors will convene on 26 March 2026. The agenda includes consideration and approval of the consolidated annual results for the financial year ended 31 December 2025 and deliberation on a potential final dividend proposal.
The notice, dated 16 March 2026, confirms that Chairman Wang Guohui will preside over the session. The current board comprises three executive directors (Wang Guohui, Zhang Kun, Wei Jiawei), three non-executive directors (Ding Kui, Chen Shaoxiong, Chen Gang) and three independent non-executive directors (Guo Shaomu, Feng Xiangqian, Gong Ping).
No additional financial figures or dividend amounts were disclosed in the announcement.